Several studies have shown Syk as an important therapeutic target for inflammatory diseases (27, 28)—for instance, Syk was found to be activated at high levels in asthma patients and mouse models, and Syk inhibitor showed potent synergistic anti-inflammatory effects (29). This evidence concerns the gene SYK and asthma.